Compare Stocks

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ECOR electroCore	$5.65 +0.2%	$6.47	$3.83 ▼ $8.08	$33.90M	0.91	13,213 shs	7,408 shs
EYES Second Sight Medical Products		$5.67	$3.42 ▼ $12.72	$54.38M	2.55	132,982 shs	36,800 shs
FCRE Fc Global Realty	$0.10 -47.4%	$0.10	$0.03 ▼ $0.56	$38.87M	2.31	7,405 shs	11,300 shs
PEYE Precision Optics		$1.95	$1.61 ▼ $2.69	$32.98M	0.41	9,793 shs	113,500 shs
YBGJ Yubo International Biotech	$0.95	$0.64	$0.07 ▼ $1.04	$112.27M	5.5	2,176 shs	N/A

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ECOR electroCore	+0.36%	-5.84%	-18.61%	-15.70%	-17.30%
EYES Second Sight Medical Products	0.00%	0.00%	0.00%	0.00%	0.00%
FCRE Fc Global Realty	0.00%	0.00%	0.00%	0.00%	0.00%
PEYE Precision Optics	0.00%	0.00%	0.00%	0.00%	0.00%
YBGJ Yubo International Biotech	0.00%	-0.78%	+192.31%	+216.67%	+968.62%

Biden’s $374B Giveaway Into This Sector (Ad)

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ECOR electroCore	2.0187 of 5 stars	3.5	5.0	0.0	0.0	0.6	0.8	0.6
EYES Second Sight Medical Products	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCRE Fc Global Realty	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PEYE Precision Optics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
YBGJ Yubo International Biotech	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ECOR electroCore	3.00	Buy	$10.00	76.99% Upside
EYES Second Sight Medical Products	N/A	N/A	N/A	N/A
FCRE Fc Global Realty	N/A	N/A	N/A	N/A
PEYE Precision Optics	N/A	N/A	N/A	N/A
YBGJ Yubo International Biotech	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest ECOR, YBGJ, EYES, FCRE, and PEYE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/14/2024	ECOR electroCore	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ECOR electroCore	$16.03M	2.11	N/A	N/A	$1.24 per share	4.56
EYES Second Sight Medical Products	$3.38M	0.00	N/A	N/A	$4.80 per share	0.00
FCRE Fc Global Realty	$40K	971.79	N/A	N/A	N/A	∞
PEYE Precision Optics	$15.68M	0.00	N/A	N/A	$0.53 per share	0.00
YBGJ Yubo International Biotech	$610K	184.05	N/A	N/A	N/A	∞

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ECOR electroCore	-$18.83M	-$3.56	N/A	N/A	N/A	-117.49%	-201.47%	-109.61%	5/1/2024 (Estimated)
EYES Second Sight Medical Products	-$8.92M	N/A	0.00	N/A	N/A	N/A	-13.58%	-13.02%	N/A
FCRE Fc Global Realty	-$2.04M	N/A	0.00	∞	N/A	-4,265.28%	-24.94%	-9.42%	N/A
PEYE Precision Optics	-$930K	-$0.06	N/A	N/A	N/A	-5.93%	-12.10%	-6.41%	N/A
YBGJ Yubo International Biotech	-$1.20M	N/A	0.00	∞	N/A	-196.21%	N/A	-59.96%	N/A

Latest ECOR, YBGJ, EYES, FCRE, and PEYE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/13/2024	Q4 2023	ECOR electroCore	-$0.55	-$0.61	-$0.06	-$0.61	$5.23 million	$5.19 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
EYES Second Sight Medical Products	N/A	N/A	N/A	N/A	N/A
FCRE Fc Global Realty	N/A	N/A	N/A	N/A	N/A
PEYE Precision Optics	N/A	N/A	N/A	N/A	N/A
YBGJ Yubo International Biotech	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ECOR electroCore	N/A	1.76	1.49
EYES Second Sight Medical Products	N/A	22.15	22.15
FCRE Fc Global Realty	N/A	0.01	0.01
PEYE Precision Optics	0.23	1.42	0.76
YBGJ Yubo International Biotech	N/A	0.25	0.18

Ownership

Institutional Ownership

Company	Institutional Ownership
ECOR electroCore	26.74%
EYES Second Sight Medical Products	N/A
FCRE Fc Global Realty	N/A
PEYE Precision Optics	N/A
YBGJ Yubo International Biotech	N/A

Insider Ownership

Company	Insider Ownership
ECOR electroCore	13.14%
EYES Second Sight Medical Products	47.20%
FCRE Fc Global Realty	5.04%
PEYE Precision Optics	22.70%
YBGJ Yubo International Biotech	56.48%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ECOR electroCore	68	6.00 million	5.21 million	Not Optionable
EYES Second Sight Medical Products	15	13.14 million	6.94 million	Optionable
FCRE Fc Global Realty	N/A	389.10 million	N/A	Not Optionable
PEYE Precision Optics	50	16.92 million	13.08 million	Not Optionable
YBGJ Yubo International Biotech	20	118.18 million	51.43 million	Not Optionable

ECOR, YBGJ, EYES, FCRE, and PEYE Headlines

Source	Headline
	Yubo International Biotech Limited (OTCMKTS:YBGJ) Short Interest Update americanbankingnews.com - April 11 at 2:12 AM
	Yubo International Biotech (OTCMKTS:YBGJ) Shares Down 3.3% americanbankingnews.com - April 10 at 1:58 AM
	Forever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion market scmp.com - January 3 at 3:49 PM
	Promontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer Cluster finance.yahoo.com - October 1 at 11:05 PM
	SABAH OFFERS TREASURE TROVE OF GENETIC RESOURCES FOR BIOTECH - MINISTER bernama.com - September 10 at 5:41 PM
	As biotech conference arrives in Boston, Wu launches push to diversify industry wgbh.org - July 6 at 1:33 PM
	Yubo International Biotech Ltd. wsj.com - June 15 at 3:22 PM
	Chemical Engineering (Biotechnology) ME buffalo.edu - April 20 at 10:52 PM
	Biotechnology – A Solution to Hunger? un.org - February 12 at 2:20 AM
	Covid-19: Bharat Biotech to launch intranasal vaccine on January 26 scroll.in - January 23 at 9:07 AM
	GLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEAD mypharma-editions.com - December 25 at 2:22 PM
	Biology news phys.org - September 14 at 2:28 PM
	Biotechnology Act to Crash Cost of Vaccines, Drugs Import, Drive Research thisdaylive.com - September 12 at 3:56 AM
	Yubo International (OTC:YBGJ), Earnings Estimates, EPS, and Revenue benzinga.com - July 18 at 8:01 PM
	Yubo International (OTC:YBGJ), Analyst Ratings, Price Targets, Predictions benzinga.com - July 18 at 8:01 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
Delta Air Lines Stock Should Take Flight After Solid Report
April 10, 2024 8:41 AM
View Delta Air Lines Stock Should Take Flight After Solid Report
TKO Group Knocks Out WrestleMania Event Record
April 15, 2024 7:20 AM
View TKO Group Knocks Out WrestleMania Event Record

All Headlines

Company Descriptions

electroCore

NASDAQ:ECOR

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Second Sight Medical Products

NASDAQ:EYES

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Fc Global Realty

OTCMKTS:FCRE

FC Global Realty Incorporated operates as a real estate investment company in the United States and internationally. It holds investments in various projects, such as high-end value hotels and resort communities; residential developments; and commercial properties, such as gas station sites. The company is based in Orangeburg, New York.

Precision Optics

OTCMKTS:PEYE

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

Yubo International Biotech

OTCMKTS:YBGJ

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial